Author

K. Nishioka

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Evolutionary Biology· 1 Genetic & Genomic Medicine· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

H. Ohashi· 2 shared K. Watashi· 2 shared S. Iwami· 2 shared S. Iwanami· 2 shared T. Wakita· 2 shared A. B. Deutschlander· 1 shared A. Nakayama· 1 shared A. Zimprich· 1 shared

Activity by Year

2019-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

H. Ohashi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genetic & Genomic Medicinenpj Parkinson's DiseasePeer-reviewedApr 20, 2026

Genome-wide association study of copy number variations in Parkinson's disease

Z. Landoulsi, Ashwin Ashok Kumar Sreelatha, Kuznetsov N.…·Rachel J. Saunders-Pullman

This study conducts a genome-wide association study of copy number variations in Parkinson's disease, identifying a significant PRKN deletion but limited replication in an independent dataset.

DOI 10.1038/s41531-025-01245-z

humanGWAS summary statistics

𝕏 PostBluesky

MicrobiologybioRxivPreprintApr 14, 2020

Multidrug treatment with nelfinavir and cepharanthine against COVID-19

H. Ohashi, K. Watashi, W. Saso…·T. Wakita

This study identifies a new multidrug combination treatment for COVID-19 using nelfinavir and cepharanthine, showing synergistic antiviral effects and improved disease control.

DOI 10.1101/2020.04.14.039925

experimental assaydrug response / drug discovery

𝕏 PostBluesky

Evolutionary BiologybioRxivOct 28, 2019

Two strategies underlying the trade-off of hepatitis C virus proliferation: stay-at-home or leaving-home?

S. Iwanami, K. Kitagawa, Y. Asai…·K. Watashi

This study analyzes the trade-off between two HCV proliferation strategies, finding that Jc1-n favors transmission while JFH-1 favors intracellular replication.

DOI 10.1371/journal.pbio.3000562

humanbulk RNA-seq

𝕏 PostBluesky